Back in January this year, we summarised the key trends our market access experts believed would dom...
Read moreThe statutory scheme has been updated with new percentages for 2024-2026, and has received backlash ...
Read moreGermany’s Health minister has announced that publicly listed AMNOG rebates could be replaced by co...
Read moreAIFA reform is a landmark change which propels Italy towards expedited drug approvals and improved a...
Read moreGovernment, NHS, and Pharma Industry Unveil Successor to Voluntary Scheme for Branded Medicines Pric...
Read moreWe're thrilled to announce our participation at ISPOR Europe 2023 in Copenhagen this November. We'll...
Read moreWe summarise the World Orphan Drug Congress Europe 2023 including keynote and panel sessions on EU H...
Read moreWe've updated our 2019 analysis which compares the annual and lifetime treatment costs of the 10 mos...
Read moreThis research aims to understand if just three PICOs are feasible by analysing recent HTA assessment...
Read moreOur research aims to gauge awareness of the new EU HTA process within the pharmaceutical industry in...
Read more